For instance, unfavorable prognostic markers belonging to the PERK-mediated UPR pathway, such as eIF2α, ATF4, GADD34, and CHOP, have been widely reported as key regulators of HCC chemosensitivity and apoptosis in targeted HCC therapy. The gene discussed is EIF2A; the disease is hepatocellular carcinoma.